Compare ASH & PAHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ASH | PAHC |
|---|---|---|
| Founded | 1924 | 1946 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Specialty Chemicals | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.1B |
| IPO Year | 2016 | 2014 |
| Metric | ASH | PAHC |
|---|---|---|
| Price | $50.70 | $55.40 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 7 | 3 |
| Target Price | ★ $67.57 | $34.33 |
| AVG Volume (30 Days) | ★ 591.7K | 229.4K |
| Earning Date | 04-29-2026 | 05-06-2026 |
| Dividend Yield | ★ 3.40% | 0.95% |
| EPS Growth | N/A | ★ 1883.33 |
| EPS | N/A | ★ 1.32 |
| Revenue | ★ $1,824,000,000.00 | $833,350,000.00 |
| Revenue This Year | $2.52 | $17.03 |
| Revenue Next Year | $3.74 | $3.82 |
| P/E Ratio | ★ N/A | $38.56 |
| Revenue Growth | N/A | ★ 4.12 |
| 52 Week Low | $45.21 | $16.16 |
| 52 Week High | $65.65 | $56.30 |
| Indicator | ASH | PAHC |
|---|---|---|
| Relative Strength Index (RSI) | 35.10 | 63.75 |
| Support Level | $50.04 | $37.09 |
| Resistance Level | $52.02 | $56.14 |
| Average True Range (ATR) | 1.88 | 2.48 |
| MACD | -0.31 | 0.12 |
| Stochastic Oscillator | 22.64 | 98.05 |
Ashland Inc. is a specialty materials company serving markets including pharmaceuticals, personal care, food and beverages, coatings, construction, energy, and electronics. It operates through four segments: Life Sciences, Personal Care, Specialty Additives, and Intermediates. Life Sciences contributes the highest revenue, offering functional additives for pharmaceutical and nutrition applications. Personal Care provides ingredients for skin, hair, oral care, and household products, while Specialty Additives supplies performance-enhancing additives for coatings and. Intermediates produce BDO and related derivatives used in polymers, electronics, agriculture, and pharmaceutical applications. The company generates sales across North America, Europe, Asia Pacific, Latin America, and regions.
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.